You may also like
Thoratec Gets European Okay for IVAD Heart Pump
CHICAGO (Reuters) – Cardiovascular device maker Thoratec Corp. said on Monday it has received European marketing approval for the Thoratec IVAD, an […]
1 min read
Combined Use of Platelet-Rich Plasma and Bone Grafting With or Without Guided Tissue Regeneration in the Treatment of Anterior Interproximal Defects
The purpose of the present study was to evaluate the efficacy of PRP when used in combination with beta-tricalcium phosphate (beta-TCP) alloplastic graft material and collagen barrier membrane in the treatment of anterior interproximal intrabony defects.
1 min read
The Current Place of Aprotinin in the Management of Bleeding
Following its withdrawal in 2007, which is explained in detail in this review, the regulators have now licensed aprotinin for myocardial revascularisation only, which is relatively low-risk for bleeding.
1 min read